HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eva Poveda Selected Research

Reverse Transcriptase Inhibitors

11/2021Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eva Poveda Research Topics

Disease

19Infections
01/2022 - 01/2010
11Hepatitis C
01/2017 - 08/2011
10HIV Infections (HIV Infection)
10/2017 - 07/2005
7Acquired Immunodeficiency Syndrome (AIDS)
11/2021 - 06/2008
7Chronic Hepatitis C
10/2013 - 08/2011
4COVID-19
01/2022 - 10/2021
4Fibrosis (Cirrhosis)
11/2021 - 01/2014
3Neoplasms (Cancer)
05/2022 - 01/2017
3Viremia
01/2022 - 10/2014
3Hepatitis B
01/2021 - 04/2013
3Coinfection
01/2017 - 09/2013
3Liver Cirrhosis (Hepatic Cirrhosis)
10/2016 - 01/2012
3Hepatitis D
10/2012 - 01/2011
2Chronic Hepatitis B
09/2013 - 10/2012
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2022
1Heart Diseases (Heart Disease)
11/2021
1Hypertension (High Blood Pressure)
11/2021
1Diabetes Mellitus
11/2021
1Chronic Renal Insufficiency
11/2021
1Virus Diseases (Viral Diseases)
01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2017
1Chronic Disease (Chronic Diseases)
07/2016
1Shock
10/2014
1Exanthema (Rash)
01/2014
1Lung Neoplasms (Lung Cancer)
01/2014
1Myocardial Infarction
01/2014
1Abdominal Obesity
01/2014
1Syphilis
10/2013
1Superinfection
04/2013
1Renal Insufficiency (Renal Failure)
10/2008
1Tropical Spastic Paraparesis (Tropical Spastic Paraplegia)
01/2003

Drug/Important Bio-Agent (IBA)

11RNA (Ribonucleic Acid)IBA
01/2022 - 01/2011
11Antiviral Agents (Antivirals)IBA
01/2017 - 04/2006
7Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2021 - 01/2011
4Pharmaceutical PreparationsIBA
11/2021 - 01/2010
4DNA (Deoxyribonucleic Acid)IBA
10/2014 - 10/2011
3Ribavirin (Virazole)FDA LinkGeneric
01/2018 - 08/2011
3Hepatitis B e AntigensIBA
09/2013 - 01/2011
3InterferonsIBA
06/2013 - 01/2012
3MaravirocFDA Link
12/2011 - 01/2010
2Immunoglobulin G (IgG)IBA
01/2022 - 10/2021
2AntibodiesIBA
10/2021 - 04/2013
2Viral RNAIBA
01/2018 - 10/2013
2Proteins (Proteins, Gene)FDA Link
10/2017 - 08/2014
2Tenofovir (Viread)FDA Link
09/2013 - 06/2008
1VaccinesIBA
01/2022
1Interleukin-2 (IL2)IBA
01/2022
1PerforinIBA
01/2022
1RacivirIBA
11/2021
1Reverse Transcriptase InhibitorsIBA
11/2021
1NucleosidesIBA
11/2021
1NucleotidesIBA
11/2021
1CytokinesIBA
10/2021
1Interleukin-6 (Interleukin 6)IBA
10/2021
1Interleukin-8 (Interleukin 8)IBA
10/2021
1Immunoglobulin M (IgM)IBA
10/2021
1Immunoglobulin A (IgA)IBA
10/2021
1Interferon-alpha (Interferon Alfa)IBA
01/2021
1N-acetoacetyl-N-deacetylcolchicineIBA
01/2017
1Mitochondrial DNA (mtDNA)IBA
10/2016
1Monoclonal AntibodiesIBA
07/2016
1Histone MethyltransferasesIBA
10/2014
1Histone Deacetylase InhibitorsIBA
10/2014
1MethyltransferasesIBA
10/2014
1Protein Kinase CIBA
10/2014
1Peptide Hydrolases (Proteases)FDA Link
08/2014
1HDL CholesterolIBA
01/2014
1Transaminases (Aminotransferases)IBA
01/2014
1Glucose (Dextrose)FDA LinkGeneric
01/2014
1Triglycerides (Triacylglycerol)IBA
01/2014
1ReaginsIBA
10/2013
1Protease Inhibitors (Protease Inhibitor)IBA
01/2013
1Inosine TriphosphataseIBA
03/2012
1LDL CholesterolIBA
03/2012
1InterleukinsIBA
03/2012
1alisporivirIBA
08/2011
1Lamivudine (Epivir)FDA Link
01/2011
1tipranavirFDA Link
07/2010
1Darunavir (Prezista)FDA Link
07/2010
1efavirenz (Sustiva)FDA Link
01/2010
1etravirine (TMC-125)FDA Link
01/2010
1Nevirapine (Viramune)FDA Link
01/2010
1Cytochrome P-450 CYP3A InhibitorsIBA
10/2008
1Enfuvirtide (Fuzeon)FDA Link
07/2005

Therapy/Procedure

15Therapeutics
04/2018 - 01/2011
3Art Therapy
05/2022 - 01/2017
2Duration of Therapy
01/2018 - 06/2013
2Highly Active Antiretroviral Therapy (HAART)
01/2017 - 07/2016
1Length of Stay
01/2017
1MVC regimen
01/2014
1Transplantation
01/2003